The findings shed light on the underlying mechanism of neurodevelopmental disorder caused by PLPPR4 mutations and suggest that PLPPR4 is a potential target for gene therapy in disorders of neuronal development. Here, PLPPR4 is linked to neurodevelopmental disorder.